RT info:eu-repo/semantics/article
T1 The impact of the COVID-19 pandemic on influenza vaccination attitudes and actions in Spain’s adult population
A1 Prada García, María del Camino
A1 Toquero Asensio, Marina
A1 Fernández Espinilla, Virginia
A1 Hernán García, Cristina
A1 Sanz Muñoz, Iván
A1 Calvo Nieves, María Dolores
A1 Eiros Bouza, José María
A1 Castrodeza Sanz, José Javier
K1 Influenza Virus
K1 Vaccines
K1 Immunotherepy
K1 Virology
K1 Pharmacology
K1 COVID-19
K1 Respiratory infections
K1 Respiratorio, Aparato - Infecciones
K1 Actitud (Psicología)
K1 Vaccination
K1 Vacunas - España
K1 Older people - Spain
K1 Public health
K1 2412 Inmunología
K1 2420 Virología
K1 3209 Farmacología
K1 3212 Salud Publica
AB Seasonal influenza is an acute respiratory infection caused by the influenza virus which constitutes a significant public health issue associated with high morbidity and mortality. The aim of this study was to investigate changes in attitudes, perceptions, and practices regarding influenza vaccination in the Spanish adult population during the COVID-19 pandemic, as well as their vaccination intentions, with special attention paid to those over 65 years old and in high-risk groups. To this end, a cross-sectional study was conducted through 2219 telephone interviews, and the results were compared with results obtained a year earlier. Regarding the reasons for deciding to get vaccinated in the 2022/23 season, a significant increase was observed in vaccine confidence (36.7% vs. 42.8%), social responsibility (32.5% vs. 43.8%), and in awareness of the importance of vaccination due to COVID-19 (21.7% vs. 25.4%). Advanced age (OR 2.8, 95% CI 2.0–3.9), belonging to high-risk groups (OR 2.7, 95% CI 2.0–3.7), and prior vaccination (OR 25.3, 95% CI 19.5–32.7) emerged as significant predictors for the intent to receive the influenza vaccine in the 2022/23 season. Continuously observing shifts in perceptions and behaviors related to influenza immunization is crucial to pinpoint factors that may influence the willingness to receive the vaccine and, in this way, design public health strategies that achieve a greater acceptance of it.
PB MDPI
SN 2076-393X
YR 2023
FD 2023
LK https://uvadoc.uva.es/handle/10324/66894
UL https://uvadoc.uva.es/handle/10324/66894
LA eng
NO Vaccines, 2023, Vol. 11, Nº. 10, 1514
NO Producción Científica
DS UVaDOC
RD 14-oct-2024